Global Circulating Tumor Cell Detection System Market Growth 2024-2030

Publication ID:

LPI04243083

Publication Date:

April 19, 2024

Pages:

117

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Research shows that when cancer metastasizes, tumor cells can escape from the primary tumor and enter the patient's peripheral blood to form so-called circulating tumor cells (CTCs). When they metastasize to the stromal microenvironment formed by appropriate organs or tissues, new tumors may form. The tumor cells released when solid tumors or lesions metastasize are an important cause of postoperative recurrence and distant metastasis in patients with malignant tumors, and are also an important factor leading to the death of tumor patients. Currently, they have been confirmed by research to include breast cancer and lung cancer. Diagnostic and prognostic markers for various cancers, including pancreatic cancer, colorectal cancer, etc. Therefore, if circulating tumor cells can be quickly detected in the blood and their number, type and characteristics can be assessed, it will help monitor tumor recurrence, evaluate drug efficacy, assist treatment decisions and adjust treatment plans, and provide better treatment for patients. Treatment and Care.
The global Circulating Tumor Cell Detection System market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
The 鈥淐irculating Tumor Cell Detection System Industry Forecast鈥� looks at past sales and reviews total world Circulating Tumor Cell Detection System sales in 2023, providing a comprehensive analysis by region and market sector of projected Circulating Tumor Cell Detection System sales for 2024 through 2030. With Circulating Tumor Cell Detection System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circulating Tumor Cell Detection System industry.
This Insight Report provides a comprehensive analysis of the global Circulating Tumor Cell Detection System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Circulating Tumor Cell Detection System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Circulating Tumor Cell Detection System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circulating Tumor Cell Detection System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circulating Tumor Cell Detection System.
United States market for Circulating Tumor Cell Detection System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Circulating Tumor Cell Detection System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Circulating Tumor Cell Detection System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Circulating Tumor Cell Detection System players cover Watson Biotech, Epione Med, RareCyte, Bio-Rad and Wuhan Youzhiyou Medical Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cell Detection System market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Detection Kit
Testing Equipment
Segmentation by application
Clinical Application
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Watson Biotech
Epione Med
RareCyte
Bio-Rad
Wuhan Youzhiyou Medical Technology
Meijing Medical
BGI
Watson Bio
Rarecells
ANGLE plc
Miltenyi Biotec
Menarini Silicon Biosystems
Key Questions Addressed in this Report
What is the 10-year outlook for the global Circulating Tumor Cell Detection System market?
What factors are driving Circulating Tumor Cell Detection System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Circulating Tumor Cell Detection System market opportunities vary by end market size?
How does Circulating Tumor Cell Detection System break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cell Detection System Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Circulating Tumor Cell Detection System by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Circulating Tumor Cell Detection System by Country/Region, 2019, 2023 & 2030
2.2 Circulating Tumor Cell Detection System Segment by Type
2.2.1 Detection Kit
2.2.2 Testing Equipment
2.3 Circulating Tumor Cell Detection System Sales by Type
2.3.1 Global Circulating Tumor Cell Detection System Sales Market Share by Type (2019-2024)
2.3.2 Global Circulating Tumor Cell Detection System Revenue and Market Share by Type (2019-2024)
2.3.3 Global Circulating Tumor Cell Detection System Sale Price by Type (2019-2024)
2.4 Circulating Tumor Cell Detection System Segment by Application
2.4.1 Clinical Application
2.4.2 Scientific Research
2.5 Circulating Tumor Cell Detection System Sales by Application
2.5.1 Global Circulating Tumor Cell Detection System Sale Market Share by Application (2019-2024)
2.5.2 Global Circulating Tumor Cell Detection System Revenue and Market Share by Application (2019-2024)
2.5.3 Global Circulating Tumor Cell Detection System Sale Price by Application (2019-2024)
3 Global Circulating Tumor Cell Detection System by Company
3.1 Global Circulating Tumor Cell Detection System Breakdown Data by Company
3.1.1 Global Circulating Tumor Cell Detection System Annual Sales by Company (2019-2024)
3.1.2 Global Circulating Tumor Cell Detection System Sales Market Share by Company (2019-2024)
3.2 Global Circulating Tumor Cell Detection System Annual Revenue by Company (2019-2024)
3.2.1 Global Circulating Tumor Cell Detection System Revenue by Company (2019-2024)
3.2.2 Global Circulating Tumor Cell Detection System Revenue Market Share by Company (2019-2024)
3.3 Global Circulating Tumor Cell Detection System Sale Price by Company
3.4 Key Manufacturers Circulating Tumor Cell Detection System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Circulating Tumor Cell Detection System Product Location Distribution
3.4.2 Players Circulating Tumor Cell Detection System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Circulating Tumor Cell Detection System by Geographic Region
4.1 World Historic Circulating Tumor Cell Detection System Market Size by Geographic Region (2019-2024)
4.1.1 Global Circulating Tumor Cell Detection System Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Circulating Tumor Cell Detection System Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Circulating Tumor Cell Detection System Market Size by Country/Region (2019-2024)
4.2.1 Global Circulating Tumor Cell Detection System Annual Sales by Country/Region (2019-2024)
4.2.2 Global Circulating Tumor Cell Detection System Annual Revenue by Country/Region (2019-2024)
4.3 Americas Circulating Tumor Cell Detection System Sales Growth
4.4 APAC Circulating Tumor Cell Detection System Sales Growth
4.5 Europe Circulating Tumor Cell Detection System Sales Growth
4.6 Middle East & Africa Circulating Tumor Cell Detection System Sales Growth
5 Americas
5.1 Americas Circulating Tumor Cell Detection System Sales by Country
5.1.1 Americas Circulating Tumor Cell Detection System Sales by Country (2019-2024)
5.1.2 Americas Circulating Tumor Cell Detection System Revenue by Country (2019-2024)
5.2 Americas Circulating Tumor Cell Detection System Sales by Type
5.3 Americas Circulating Tumor Cell Detection System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor Cell Detection System Sales by Region
6.1.1 APAC Circulating Tumor Cell Detection System Sales by Region (2019-2024)
6.1.2 APAC Circulating Tumor Cell Detection System Revenue by Region (2019-2024)
6.2 APAC Circulating Tumor Cell Detection System Sales by Type
6.3 APAC Circulating Tumor Cell Detection System Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Circulating Tumor Cell Detection System by Country
7.1.1 Europe Circulating Tumor Cell Detection System Sales by Country (2019-2024)
7.1.2 Europe Circulating Tumor Cell Detection System Revenue by Country (2019-2024)
7.2 Europe Circulating Tumor Cell Detection System Sales by Type
7.3 Europe Circulating Tumor Cell Detection System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Circulating Tumor Cell Detection System by Country
8.1.1 Middle East & Africa Circulating Tumor Cell Detection System Sales by Country (2019-2024)
8.1.2 Middle East & Africa Circulating Tumor Cell Detection System Revenue by Country (2019-2024)
8.2 Middle East & Africa Circulating Tumor Cell Detection System Sales by Type
8.3 Middle East & Africa Circulating Tumor Cell Detection System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Circulating Tumor Cell Detection System
10.3 Manufacturing Process Analysis of Circulating Tumor Cell Detection System
10.4 Industry Chain Structure of Circulating Tumor Cell Detection System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Circulating Tumor Cell Detection System Distributors
11.3 Circulating Tumor Cell Detection System Customer
12 World Forecast Review for Circulating Tumor Cell Detection System by Geographic Region
12.1 Global Circulating Tumor Cell Detection System Market Size Forecast by Region
12.1.1 Global Circulating Tumor Cell Detection System Forecast by Region (2025-2030)
12.1.2 Global Circulating Tumor Cell Detection System Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Circulating Tumor Cell Detection System Forecast by Type
12.7 Global Circulating Tumor Cell Detection System Forecast by Application
13 Key Players Analysis
13.1 Watson Biotech
13.1.1 Watson Biotech Company Information
13.1.2 Watson Biotech Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.1.3 Watson Biotech Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Watson Biotech Main Business Overview
13.1.5 Watson Biotech Latest Developments
13.2 Epione Med
13.2.1 Epione Med Company Information
13.2.2 Epione Med Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.2.3 Epione Med Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Epione Med Main Business Overview
13.2.5 Epione Med Latest Developments
13.3 RareCyte
13.3.1 RareCyte Company Information
13.3.2 RareCyte Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.3.3 RareCyte Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 RareCyte Main Business Overview
13.3.5 RareCyte Latest Developments
13.4 Bio-Rad
13.4.1 Bio-Rad Company Information
13.4.2 Bio-Rad Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.4.3 Bio-Rad Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bio-Rad Main Business Overview
13.4.5 Bio-Rad Latest Developments
13.5 Wuhan Youzhiyou Medical Technology
13.5.1 Wuhan Youzhiyou Medical Technology Company Information
13.5.2 Wuhan Youzhiyou Medical Technology Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.5.3 Wuhan Youzhiyou Medical Technology Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Wuhan Youzhiyou Medical Technology Main Business Overview
13.5.5 Wuhan Youzhiyou Medical Technology Latest Developments
13.6 Meijing Medical
13.6.1 Meijing Medical Company Information
13.6.2 Meijing Medical Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.6.3 Meijing Medical Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Meijing Medical Main Business Overview
13.6.5 Meijing Medical Latest Developments
13.7 BGI
13.7.1 BGI Company Information
13.7.2 BGI Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.7.3 BGI Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 BGI Main Business Overview
13.7.5 BGI Latest Developments
13.8 Watson Bio
13.8.1 Watson Bio Company Information
13.8.2 Watson Bio Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.8.3 Watson Bio Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Watson Bio Main Business Overview
13.8.5 Watson Bio Latest Developments
13.9 Rarecells
13.9.1 Rarecells Company Information
13.9.2 Rarecells Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.9.3 Rarecells Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Rarecells Main Business Overview
13.9.5 Rarecells Latest Developments
13.10 ANGLE plc
13.10.1 ANGLE plc Company Information
13.10.2 ANGLE plc Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.10.3 ANGLE plc Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 ANGLE plc Main Business Overview
13.10.5 ANGLE plc Latest Developments
13.11 Miltenyi Biotec
13.11.1 Miltenyi Biotec Company Information
13.11.2 Miltenyi Biotec Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.11.3 Miltenyi Biotec Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Miltenyi Biotec Main Business Overview
13.11.5 Miltenyi Biotec Latest Developments
13.12 Menarini Silicon Biosystems
13.12.1 Menarini Silicon Biosystems Company Information
13.12.2 Menarini Silicon Biosystems Circulating Tumor Cell Detection System Product Portfolios and Specifications
13.12.3 Menarini Silicon Biosystems Circulating Tumor Cell Detection System Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Menarini Silicon Biosystems Main Business Overview
13.12.5 Menarini Silicon Biosystems Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂